by GlobeNewsWire | Aug 4, 2016 | Globe Newswire
CAMBRIDGE, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today announced its second quarter...
by GlobeNewsWire | Jul 27, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif. and WASHINGTON, July 27, 2016 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (Nasdaq:CYTK) and The ALS Association today announced the continuation and expansion of their partnership in the fight against ALS, including Cytokinetics’ renewal of...
by GlobeNewsWire | Jul 5, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., July 05, 2016 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (Nasdaq:CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at Cantor Fitzgerald’s 2nd Annual Healthcare...
by GlobeNewsWire | Jul 4, 2016 | Globe Newswire
TORONTO, July 04, 2016 (GLOBE NEWSWIRE) — Nevada Zinc Corporation (“Nevada Zinc” or the “Company”) (TSX-V:NZN) is pleased to report assay results for 10 reverse circulation drill holes from its ongoing drill program on the Company’s Mountain View Mine which is...
by GlobeNewsWire | Jun 30, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., June 30, 2016 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (Nasdaq:CYTK) today announced the start of a randomized, double-blind, placebo-controlled, two period crossover clinical trial designed to assess the effect of CK-2127107 (CK-107)...